Idera KOL Event at ASCO
You are invited to the Idera Pharmaceuticals (IDRA) KOL presentation on June 4 of ILLUMINATE 204 Tilsotolimod data and Q&A with Adi Diab, MD during ASCO.
The event will include a presentation from Adi Diab, MD, Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center.
Hyatt Regency McCormick Place
2233 S Dr. Martin Luther King Jr. Drive
Food and beverages will be provided.
For more information, please contact Alan Lada at email@example.com.
Adi Diab, MD
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine
MD Anderson Cancer Center
Adi Diab, MD, is a clinical investigator whose research is focused on developing new Immunotherapeutic Strategies that will improve clinical outcomes in patients. Building on his extensive background in immunology in general and tumor immunology specifically, Dr Diab is leading multiple clinical trials involving novel immune modulator agent with Melanoma. In addition he is leading a program for Interventional Immunotherapy that was established to develop intratumoral therapeutic strategies in combination with Systemic therapy; designed to improve clinical outcome and allow better understanding of the dynamics of each patient’s immune response to the tumor. These strategies include tumor ablation such as Cryoablation, RFA or Radiation therapy as well as direct intratumoral injection of immune modulation agents such as TLR agonists, CD40 agonists and other immune-stimulating agents.
He has authored or co-authored over thirty scientific publications and abstracts and serves as a reviewer for the Journal of Immunotherapy and the Journal of the American Society of Hematology.
Dr Diab received his medical degree from St. George’s University. He completed a research fellowship in immunology at Memorial Sloan-Kettering Cancer Center. Following his residency at New York University Medical Center, Dr Diab completed clinical fellowships at Memorial Sloan-Kettering Cancer Center in hematology oncology and breast medical oncology.
Dr Diab is board certified in internal medicine and medical oncology
June 4, 2018
Registration: 6:00pm CT
Presentation: 6:30pm CT
Location of the Event and Other Places